Ketogenic diets: Additional benefits to the weight loss and unfounded secondary effects;Las dietas cetogénicas: Bénéficies adicionales a la pérdida de peso y efectos secyndarios infyndados

Archivos Latinoamericanos de Nutricion

Volumn 58, Issue 4, 2008, Pages 323-329

  Pérez Guisado, Joaquin ^a  

^a Universidad de Cordoba   (Spain)

Author keywords

Atkins; Cancer; Diabetes; Epilepsy; Glucose intolerance

Indexed keywords

INSULIN; KETONE BODY;

ARTICLE; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; DIET THERAPY; GLUCOSE BLOOD LEVEL; HUMAN; KETOACIDOSIS; KETOGENIC DIET; LOW CARBOHYDRATE DIET; METABOLISM; NEOPLASM; OBESITY; PHYSIOLOGY; STANDARD; WEIGHT REDUCTION;

BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIET, CARBOHYDRATE-RESTRICTED; HUMANS; INSULIN; KETOGENIC DIET; KETONE BODIES; KETOSIS; NEOPLASMS; OBESITY; WEIGHT LOSS;

EID: 67849086603     PISSN: 00040622     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. Al-Zaid NS, Dashti HM. Mathew TC, Juggi JS. Low carbohydrate ketogenic diet enhances cardiac tolerance to global ischaemia. Acta Cardiol. 2007: 62:381-9.
2. Parks EJ, Flellerstein MK. Carbohydrate4nduced Hypertriacylglycerolemia: Historical Perspective and Review of Biological Mechanisms. Am J Clin Nutn 2000: 71: 412-33.
3. Dashti HM, Bo-Abbas YY, Asfar SK. Mathew TC. Hussein T, Behbahani A, et al. Ketogenic Diet Modifies the Risk Factors of Heart Disease in Obese Patients. Nutrition. 2003; 19: 901- 02.
4. Volek JS, Gómez AL, Kraemer WJ. Fasting Lipoprotein and Postprandial Triacylglycerol Responses to a Low-Carbohyd.rate Diet Supplemented With N-3 Fatty Acids. J Am Col Nutr.'2000; 19: 383-91.
5. Patsch JR, Miesenböck G Hopferwieser T, Mühlberger V, Knapp E, Dunn .IK, et al. Relation of triglyceride metabolism and coronary arter}' disease: studies in the postprandial state. Arterioscler Thromb. 1992; 12: 1336-45.
6. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a Cardiovascular Risk Factor. Am J Cardiol. 1998; 81: 7B- 12B.
7. Hellerstein MK. Ciirbohydrate-induced hypertriglyceridemia: modifying factors and implications for cardiovascular risk. Curr Opin Eipidol. 2002; 13: 33-40.
8. Hudgins LC. Hellerstein M, Seidman C, Neese R. Diakun J, Hirsch J. Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet.J Clin Invest. 1996; 97: 2081- 91.
9. Hudgins LC. Effect ofhighcarbohydrate feeding on triglyceride and saturated fatty acid synthesis. Proc Soc Exp Biol Med. 2000; 225: 178-83.
10. Yiincy WS .Ir, Olsen MK, Guyton JR, Bakst RP, Westman EC. A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial. Ann Intern Med. 2004; 140: 769-77.
11. Foster GD, Wyatt HR, Hill JO, McGuckin BG. Brill C, Mohammed BS, et al. A Randomized trial of a low- carbohydrate diet for obesity. N Engl J Med. 2003; 348: 2082- 90.
12. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation. 1990: 82: 49.5-.506.
13. Dreon DM, Femstrom HA, Williams PT, Krauss RM. A Very Low-Eat Diet is not Associated With Improved Lipoprotein Profiles in Men With a Predominance of Large, Low-Density Lipoproteins. Am J Clin Nutr. 1999: 69: 411-18.
14. Campos H, Dreon DM. Krauss RM. Associations of hepatic and lipoprotein lipase activities with changes in dietary composition and low-density lipoprotein subclasses. J Lipid Res. 199.5; 36:462-472.
15. Sharman MJ, Gomez AL. Kraemer WJ. Volek JS. Verj' low carbohydrate and low-fat diets affect fasting lipids and postprandial lipemia differently in overweight men. J Nutr. 2004; 134: 880-85.
16. Westman EC, Yancy WS .Tr, Olsen MK, Dudley T. Guyton JR. Effect of a low-carbohydrate, ketogenic diet program compared to a low-fat diet on fasting lipoprotein subclasses. Int J Cardiol. 2006; 110:212-16.
17. Dashti HM, Mathew TC. Khadada M. Al-Mousawi M, Talib H, Asfar SK, et al. Beneficial effects of ketogenic diet in obese diabetic subjects. Mol Cell Biochem. 2007; 302:249-56.
18. Dashti HM, Al-Zaid NS. Mathew TC, Al-Mousawi M, Talib H, Asfar SK, et al. Long term effects of ketogenic diet in obese subjects with high cholesterol level. Mol Cell Biochem. 2006: 286:1-9.
19. Pérez-Cîuisado J, Muñoz Serrano A, Alonso-Moraga A. .Spanish Ketogenic Mediterranean diet: a healthy cardiovascular diet for weight loss. Nutr J. 2008; 7:30.
20. Sondike SB, Coppemian N. Jacobson MS: Effects of a low carbohydrate diet on weight loss and cardiovascular risk factors in overweight adolescents. J Pediatr. 2003; 42: 253-58.
21. Willi SM, Oexmann MJ, Wright NM, Collup NA, Key LL Jr. The effects of a high-protein, low-fat. ketogenic diet on adolescents with morbid obesity: body composition, blood chemistries and sleep abnormalities. Pediatrics. 1998; 101:61-67.
22. Westman EC, Yancy WS, Edman JS, Tomlin KE Perkins CE. Effect of 6-month adherence to a very low carbohydrate diet program. Am J Med. 2002: 113: 30-36.
23. Brehm BJ, Daniels SR, D'Alessio DA. A Randomized Trial Comparing a Very Low Carbohydrate Diet and a Calorie-Restricted Low Fat Diet on Body Weight and Cardiovascular Risk Factors in Healthy Women. J Clin Endocrinol Metab. 2003; 88: 1617-23.
24. Stern L, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGroiy J, et al. The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults; One-year follow-up of a randomized trial. Ann Intern Med. 2004; 140:778-85.
25. Nobel s V, van Gaal L, de Leeuw I. Weight Reduction With a High Protein. Low Carbohydrate. Caloric Restricted Diet: Effects on Blood Pressure, Glucose and Insulin Levels. The Netheriands Journal of Medicine. 1989; 35: 295-302.
26. Kopp W. Pathogenesis and etiology of essential hypertension: role of dietary carbohydrate. Med Hypotheses. 2005; 64:782- 87.
27. Lucas CP, Estigarribia JA. Darga LL, Reaven GM. Insulin and Blood Pressure in Obesity. Hypertension. 1985; 7; 702-06.
28. Muscelli E, NataH A. Bianchi S, Bigazzi R. Galvan AQ, Sironi AM, et al. Effect of insulin on renal sodium and uric acid handhng in essential hypertension. Am J Hypertens. 1996; 9: 746-52.
29. Rocchini AE Proceedings of the Council for High Blood Pressure Research, 1990; Insulin Resistance and Blood Pressure Regulation in Obese and Nonobese Subjects: Special Lecture. Hypertension. 1991; 17; 837-42.
30. Stamler J, Elliott R Kesteloot H. Nichols R. Claeys G Dyer AR, et al. Inverse relation of dietary protein markers with blood pressure. Findings for 10,020 men and women in the INTERSALT Study. INTERSALT Cooperative Research Group. International study of SALT and blood pressure. Circulation. 1996, 94: 1629-34.
31. Liu L, Ikeda K, Yamori Y, WHO-CARDIAC Study Group. Inverse Relationship Between Urinary Markers of Animal Protein Intake and Blood Pressure in Chinese: Results from the WHO Cardiovascular Diseases and Alimentary Comparison (CARDIAC) Study. Int J Epidemiol. 2002; 31: 227-33.
32. Lehninger AL. Principios de Bioqufmica. Barcelona, Espana: Ediciones Omega; 1991: 531-557.
33. Okere IC, Young ME, McElfresh TA, Chess DJ, Sharov VG Sabbah HN, Hoit BD, Emsberger R Chandler MR Stanley WC. Low carbohydrate/high-fat diet attenuates cardiac hypertrophy, remodeling, and altered gene expression in hypertension. Hypertension. 2006; 48:1116-23.
34. Gannon MC. Nuttall FQ. Effect of a high-protein, low carbohydrate diet on blood glucose control in people with type 2 diabetes. Diabetes. 2004; 53: 2375-82.
35. Boden G Sargrad K, Homko C, Mozzoli M, Stein TR et al. Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med. 2005; 142: 403-11.
36. Nuttall FQ, Gannon MC. The metabolic response to a high protein, low-carbohydrate diet in men with type 2 diabetes
37. Volek JS, Sharman MJ, Gomez AL. Comparison of a Very Low Carbohydrate and Low-Fat Diet on Fasting Lipids, LDL Subclasses. Insulin Resistance, and Postprandial Lipemic Responses in Overweight Women. J Am Coll Nutr. 2004: 23; 177-84.
38. Bisschop PH, de Metz J, Ackermans MT, Endert E, Pijl H, Kuipers F et al. Dietary fat content alters insulin-mediated glucose metabolism in healthy men. Am J Clin Nutr. 2001 ; 73; 554-59.
39. Yancy WS, Foy M, Chalecki AM, Vernon MC, Westman EC. A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutr Metab 2005: 2:34.
40. Westman EC, Yancy WS, Hepburn J, Mavropoulos J. A Pilot Study of a Low-Carbohydrate, Ketogenic Diet for Obesity Related Polycystic Ovarj' Syndrome. J Gen Intern Med. 2004; I9(1S):HI.
41. Mavropoulos JC. Yancy WS, Hepburn J, Westman EC. The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: A pilot study. Nutr Metab. 2005; 2:35.
42. Major CA, Henry M.I, De Veciana M, Morgan MA. The effects of carbohydrate restriction in patients with diet-controlled gestational diabetes. Obstet Gynecol. 1998;9:600-04.
43. Pérez-Guisado J. Carbohydrates, glucose metabolism and cancer. Endocrinol Nutr 2006; 53: 252-55.Disponible: http://extemal.doyma.es/pdf/12/ 12v53n04al3086356pdf001.pdf
44. Nebeling LC. Lemer E. Implementing a ketogenic diet based on medium-chain triglyceride oil in pediatric patients with cancer. J Am Diet Assoc. 1995: 95: 693-97.
45. Nebeling LC, Miraldi F, Shurin SB, Lerner E. Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. J Am Coll Nutn 1995; 14: 202-08.
46. Beck SA, Tisdale MJ. Nitrogen excretion in cancer cachexia and its modification by a high fat diet in mice. Cancer Res. 1989; 49: 3800-04.
47. Mozaffarian D. Rimm EB, Herrington DM. Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women. Am .1 Clin Nutr. 2004; 80: 1175-84.
48. Zhou W, Mukherjee P Kiebish MA, Markis WT. Mantis JG Seyfried TN. The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutr Metab. 2007:4:5.
49. Sondike SB, Copperman NM. Jacobson MS. Low Carbohydrate Dieting Increases Weight Loss but not Cardiovascular Risk in Obese Adolescents: A Randomized Controlled Trial. J Adolesc Health. 2000; 26: 91
50. Phinney SD, Bistrian BR. Wolfe RR, Blackburn GL. The Human Metabolic Response to Chronic Ketosis Without Caloric Restriction: Physical and Biochemical Adaptation. Metabolism. 1983; 32: 7.57-68.
51. Pagan TC, Oexmann MJ. Effects of High Protein, High Carbohydrate, and High Fat Diets on Laboratory Parameters. J Am Coll Nutr. 1987; 6: 333-43.
52. Martin WF, Amstrong LE, Rodriguez NR. Dietary Protein Intake and Renal Function. Nutr Metab. 2005; 2:25.
53. Skov AR, Toubro S, Bulow J, Krabbe K, Parving HH, Astrap A. Changes in Renal Function During Weight Loss Induced by High vs Low-Protein Low-Fat Diets in Overweight Subjects. Int JObes. 1999; 23: 1170-77.
54. Knight EL, Stampfer MJ, Hankinson SE, Spiegelman D, Curhanet GC. The Impact of Protein Intake on Renal Function Decline in Women with Normal Renal Function or Mild Renal Insufficiency. Ann Intern Med. 2003; 138: 460-67.
55. Mukherjee R El Abbadi MM, Kasperzyk JL, Ranes MK, Seyfried TN. Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. Br J Cancer. 2002; 86: 1615-21.
56. Yancy WS Jr, Olsen MK, Dudley T, Westman EC. Acid-base analysis of individuals following two weight loss diets. Eur J Clin Nutr. 2007; 61:1416-22.
57. Guyton AC. Hall JE. Fisiología Médica. 9'" ed. Madrid, España: Interamericana McGraw-Hill; 1996: 927-952, 1063-1077.
58. Chen TY, Smith W, Rosenstock JL, Lessnau KD. A life threatening complication of Atkins diet. Lancet. 2006; 367: 958.
59. Pérez-Guisado J. Arguments in favor of ketogenic diets. Internet journal of nutrition and wellness, 2007; 4:2.
60. Pérez-Guisado J. Ketogenic diets and weight loss: basis and effectiveness. Arch Latinoam Nutr. 2008. 58:126-31.
61. Owen OE. Morgan AR Kemp HG Sullivan JM. Herrera MG Cahill OF Jr, et al. Metabolism During Fasting. J Clin Invest. 1967: 46: 1589-95.
62. Albero R, Sanz A, Playán J. Metabolismo en el ayuno. Endocrinol Nutr 2004;51:139-48
63. Dardzinski BJ, Smith SL, Towfighi J, Williams GD. Vannucci RC. Smith MB. Increased plasma beta-hydroxybutyrate, preserved cerebral energy metabolism, and amelioration of brain sone pretreatTtnent. Pediatr Re-s. 2000: 48: 248-55.
64. Kashiwaya Y. Takeshima T, Mori N. Nakashima K, Clarke K. Veech RL I En linea.WMF beta-hyd.roxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Nad Acad Sci USA. 2000; 97: 5440-44.
65. Langston JW. Langston EB. Irwin I. MPTP-induced parkin- mental aspects. Acta Neurol Scand. 1984. 100: 49-54.
66. Kang HC, Kim JY, Kim DW, Kim HD. Efficacy and safety of the ketogenic diet for intractable childhood epilepsy: Korean multicentric experience. Epilepsia. 2005; 46:272-79.
67. Kossoff EH. McGrogan JR. Bluml RM. Pillas DJ. Rubenstein JE, Vining EP . A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia. 2006: 47:421-24.
68. Freeman JM. Vining ER Pillas DJ. Pyzik PL. Casey JC. Kelly LM. The Efficacy of the Ketogenic Diet. A Prospective Evaluation of Inter\'ention in 150 Children. Pediatrics. 1998; 102: 1358-63.
69. Freeman JM. What every pediatrician should know about the ketogenic diet. Contemporary Pediatrics. 2003; 20:113-27.
70. Vining EPG Freeman JM. A multi-center study of the efficacy of the ketogenic diet. Archives of Neurology. 1998; 55:1433- 37.
71. Kossoff EH, Krauss GL, McGrogan JR, Freeman JM. Efficacy of the Atkins diet as therapy for intractable epilepsy. Neurology. 2003; 61: 1789-91.
72. Kossoff EH. More fat and fewer seizures: dietary therapy for epilepsy. Lancet Neurol. 2004; 3: 415-20.
73. BergqvistAG. Schall JI, Gallagher PR, CnaanA, Stalhngs VA. Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized cHnical trial of efficacy. Epilepsia. 2005; 46: 1810--19.
74. Mady MA, Kossoff EH. McGregor AL. Wheless JW. Pyzik PL, Freeman JM. The Ketogenic Diet: adolescents can do it, too. Epilepsia. 2003; 44: 847-51.
75. Sirven J, Whedon B, Caplan D. The ketogenic diet for intractable epilepsy in adults: preliminary results. Epilepsia. 1999; 40: 1721-26.
76. Henderson ST.Ketone bodies as a therapeutic for Alzheimer's disease Neurotherapeutice 2008 .jul:5(.3):470-80.
77. Hannan MT. Tucker KL, Dawson-Hughes B, Cupples LA, Felson DT, Kiel DP. Effect of Dietaiy Protein on Bone Loss in Elderly Men and Women: The Framingham Osteoporosis Study. .1 Bone Miner Res. 2000: 15: 2504-12.
78. Kerstetter JE, O'Brien KO. Caseria DM, Wall DE, Insogna KL. The Impact of Dietary Protein on Calcium Absorption and Kinetic Measures of Bone Turnover in Women. J Clin Endocrinol Metab. 2005; 90: 26-31.
79. Dawson-Hughes B, Harris SS, Rasmussen H. Song L, Dallai GE. Effect of Dietary Protein Supplements on Calcium Excretion in Healthy Older Men and Women. J CUn Endocrinol Metab. 2004; 89: 1169-73.
80. Heaney RP . Dietary Protein and Phosphorous Do not Affect Calcium Absorption. Am J Clin Nutr. 2000; 72: 758-61.
81. Heaney, RP. Excess Dietarj' Protein May not Adversely Affect Bone. J Nutr. 1998, 128: 1054-57.
82. Ponce GM. Fajardo MA, Zeni SN. de Portela ML. Ingesta de calcio y protefnas: relación con marcadores bioquimicos óseos en mujeres pre y posmenopáusicas de Comodoro Rivadavia (Argentina). Arch Latinoamer Nutr. 2006: 56: 237-243.
83. Caballero C, Hernández B, Moreno H. Hernández-Girón C, Campero L, Cruz A, et al. Obesidad, actividad e inactividad ffsica en adolescentes de Morelos. México: un estudio longitudinal Arch Lat Nutr 2007, 57: 10-17.
84. Lambert EV. Speechly DP Dennis SC. Noakes TD. Enhanced Endurance in Trained Cyclists During Moderate Intensity Exercise Following 2 Weeks Adaptation to a High Fat Diet. Eur J Appl Physiol Occup Physiol. 1994; 69: 287-93.
85. Phinney SD. Ketogenic diets and physical performance. Nutr Metabol. 2004: 1:1-7.
86. Pérez-Guisado J. C Athletic performance: muscle glycogen and protein intake. Apunts Medicina de I'Esport. 2008; 43:159. Disponible: http://www.apunts.org/cgi-bin/wdbcgi.exe/apunts/ mrevista.resumen?pident=l 3126396
87. Jarrets SG, Milder JB, Liang LP Patel M. The ketogenic diet increase mitochondrial glutathione levels. J Neurochem. 2008; 106:1044-51.
88. Ilaces ML, Hernández-Fonseca K, Medina-Campos ON. Montiel T, Pedraza-Chaverri J. Massieu L. Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions. Exp Neurol. 2008; 211:85-96.